Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways
London and Toronto (ots/PRNewswire) - Apollon Formularies plc (AQSE:
APOL) ("Apollon" or the "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) ("Aion"), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms:!-->…